3,4-Methylenedioxyphentermine
A psychoactive drug of the phenethylamine and amphetamine classes
| 3,4-Methylenedioxyphentermine | |
|---|---|
| INN | |
| Drug class | |
| Routes of administration | Oral |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | Uncontrolled |
| CAS Number | 32052-16-3 |
| PubChem | 4436 |
| DrugBank | |
| ChemSpider | 4283 |
| KEGG | |
3,4-Methylenedioxyphentermine (MDPH) is a psychoactive drug of the phenethylamine and amphetamine chemical classes. It is structurally related to 3,4-methylenedioxyamphetamine (MDA) and 3,4-methylenedioxymethamphetamine (MDMA), which are well-known recreational drugs.
Chemical structure and properties
3,4-Methylenedioxyphentermine is a derivative of amphetamine with a methylenedioxy group attached to the phenyl ring. The chemical formula is C10H13NO2, and it has a molecular weight of 179.22 g/mol. The presence of the methylenedioxy group is thought to contribute to its psychoactive properties.
Pharmacology
MDPH acts as a central nervous system stimulant. It is believed to exert its effects by increasing the release of neurotransmitters such as dopamine, norepinephrine, and serotonin in the brain. This action is similar to that of other amphetamines and is responsible for its stimulant and empathogenic effects.
Effects
The effects of 3,4-methylenedioxyphentermine are not well-documented, but it is thought to produce effects similar to those of MDA and MDMA, including increased energy, euphoria, and enhanced sensory perception. However, due to limited research, the full range of effects and potential risks are not well understood.
Legal status
3,4-Methylenedioxyphentermine is not a controlled substance in most jurisdictions, but its structural similarity to other controlled substances may subject it to regulation under analogue laws.
Synthesis
The synthesis of MDPH involves the reaction of safrole with methylamine in the presence of a reducing agent. This process is similar to the synthesis of other methylenedioxy-substituted amphetamines.
Related compounds
- 3,4-Methylenedioxyamphetamine (MDA)
- 3,4-Methylenedioxymethamphetamine (MDMA)
- 3,4-Methylenedioxy-N-ethylamphetamine (MDEA)
See also
Related pages
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa
Tired of being overweight?
Get started with evidence based, physician-supervised
affordable GLP-1 weight loss injections
Now available in New York City and Philadelphia:
- Semaglutide starting from $59.99/week and up
- Tirzepatide starting from $69.99/week and up (dose dependent)
✔ Evidence-based medical weight loss ✔ Insurance-friendly visits available ✔ Same-week appointments, evenings & weekends
Learn more:
Start your transformation today with W8MD weight loss centers.
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian